Correction to: Nature Communications 10.1038/s41467-021-25952-2, published online 23 September 2021.
In this article the author name Tetsuro Izumi was incorrectly written as Testuro Izumi. The original article has been corrected.
. 2021 Oct 29;12:6342. doi: 10.1038/s41467-021-26635-8
Author Correction: Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
Miao-Miao Zhao
1,2, Jing Lu
1,2, Sen Li
2, Hao Wang
1,2,3, Xi Cao
1,2, Qi Li
2, Ting-Ting Shi
1,2, Kohichi Matsunaga
3, Chen Chen
4, Haixia Huang
5, Tetsuro Izumi
3, Jin-Kui Yang
1,2,✉
Miao-Miao Zhao
1Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730 Beijing, China
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
Find articles by Miao-Miao Zhao
Jing Lu
1Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730 Beijing, China
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
Find articles by Jing Lu
Sen Li
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
Find articles by Sen Li
Hao Wang
1Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730 Beijing, China
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
3Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan
Find articles by Hao Wang
Xi Cao
1Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730 Beijing, China
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
Find articles by Xi Cao
Qi Li
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
Find articles by Qi Li
Ting-Ting Shi
1Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730 Beijing, China
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
Find articles by Ting-Ting Shi
Kohichi Matsunaga
3Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan
Find articles by Kohichi Matsunaga
Chen Chen
4School of Biomedical Sciences, University of Queensland, Brisbane, QLD 4072 Australia
Find articles by Chen Chen
Haixia Huang
5Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, 100069 Beijing, China
Find articles by Haixia Huang
Tetsuro Izumi
3Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan
Find articles by Tetsuro Izumi
Jin-Kui Yang
1Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730 Beijing, China
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
Find articles by Jin-Kui Yang
1Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 100730 Beijing, China
2Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, 100730 Beijing, China
3Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan
4School of Biomedical Sciences, University of Queensland, Brisbane, QLD 4072 Australia
5Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, 100069 Beijing, China
✉
Corresponding author.
Collection date 2021.
Subject terms: Ion transport, Diabetes, Diabetes, Drug development
© The Author(s) 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC8556391 PMID: 34716337
This corrects the article "Berberine is an insulin secretagogue targeting the KCNH6 potassium channel", 5616.